Table 4.
Association between oral lesions (disease progression biomarkers) and various clinical and demographic factors.
| Variable | OR | Lower Limit | Upper Limit | P-value |
|---|---|---|---|---|
| 6 months | 1.00 | - | - | - |
| 12 months | 0.779 | 0.123 | 4.726 | 0.781 |
| 18 months | 0.466 | 0.077 | 2.411 | 0.372 |
| Pre-CD4 | 0.993 | 0.985 | 1.00 | 0.081 |
| Pre-CD8 | 1.001 | 1.00 | 1.004 | 0.046 |
| Post-CD4 | 1.005 | 1.001 | 1.011 | 0.080 |
| Post-CD8 | 0.997 | 0.994 | 0.999 | 0.008 |
| Age | 1.020 | 0.966 | 1.089 | 0.506 |
| Gender | 1.306 | 0.348 | 5.380 | 0.695 |
| Post CD4/CD8 | 0.197 | 0.040 | 0.899 | 0.028 |
HAART: Highly active antiretroviral therapy; CD4: Cluster of differentiation 4; CD8: Cluster of differentiation 8; OR: Odds ratio.